Tumour expression of the DNA repair protein, XPF, predicts pathological response to neoadjuvant oxaliplatin chemotherapy in oesophageal cancer

Tumour expression of the DNA repair protein, XPF, predicts pathological response to neoadjuvant oxaliplatin chemotherapy in oesophageal cancer

التفاصيل البيبلوغرافية
المؤلفون الرئيسيون:	Gillies, R, Delaney, D, Warren, B, Sharma, R, Middleton, MR
التنسيق:	Conference item
منشور في:	2011

مواد مشابهة

Metabolic response at repeat PET/CT predicts pathological response to neoadjuvant chemotherapy in oesophageal cancer
حسب: Gillies, R, وآخرون
منشور في: (2012)

Metabolic response at repeat PET/CT predicts pathological response to neoadjuvant chemotherapy in oesophageal cancer.
حسب: Gillies, R, وآخرون
منشور في: (2012)

XPF protein levels determine sensitivity of malignant melanoma cells to oxaliplatin chemotherapy: suitability as a biomarker for patient selection.
حسب: Hatch, S, وآخرون
منشور في: (2014)

Role of endonucleases XPF and XPG in nucleotide excision repair of platinated DNA and cisplatin/oxaliplatin cytotoxicity
حسب: Graf, Nora, وآخرون
منشور في: (2012)

Translational study identifies XPF and MUS81 as predictive biomarkers for oxaliplatin-based peri-operative chemotherapy in patients with esophageal adenocarcinoma
حسب: MacGregor, T, وآخرون
منشور في: (2018)

XPF protein levels determine sensitivity of malignant melanoma cells to oxaliplatin chemotherapy: Suitability as a biomarker for patient selection
حسب: Hatch, S, وآخرون
منشور في: (2014)

Translational study identifies XPF and MUS81 as predictive biomarkers for oxaliplatin-based peri-operative chemotherapy in patients with esophageal adenocarcinoma
حسب: T. P. MacGregor, وآخرون
منشور في: (2018-05-01)

Use of DNA repair proteins translated from biomarker screening to predict overall survival in patients with esophageal cancer treated with oxaliplatin chemotherapy
حسب: Sharma, R, وآخرون
منشور في: (2012)

Role of positron emission tomography-computed tomography in predicting survival after neoadjuvant chemotherapy and surgery for oesophageal adenocarcinoma.
حسب: Gillies, R, وآخرون
منشور في: (2012)

Role of positron emission tomography-computed tomography in predicting survival after neoadjuvant chemotherapy and surgery for oesophageal adenocarcinoma
حسب: Gillies, R, وآخرون
منشور في: (2012)

XPF-ERCC1: Linchpin of DNA crosslink repair
حسب: McHugh, PJ
منشور في: (2020)

Tissue-Specific DNA Repair Activity of ERCC-1/XPF-1
حسب: Mariangela Sabatella, وآخرون
منشور في: (2021-01-01)

Challenges in assessing response of oesophageal cancer to neoadjuvant therapy, and the potential of composite PET-CT and multimodal metrics.
حسب: Findlay, J, وآخرون
منشور في: (2017)

Cells deficient in the base excision repair protein, DNA polymerase beta, are hypersensitive to oxaliplatin chemotherapy.
حسب: Yang, J, وآخرون
منشور في: (2010)

Oesophageal and gastro-oesophageal junction tumours
حسب: Bird-Lieberman, E, وآخرون
منشور في: (2007)

Mislocalization of XPF-ERCC1 nuclease contributes to reduced DNA repair in XP-F patients.
حسب: Anwaar Ahmad, وآخرون
منشور في: (2010-03-01)

Metabolic nodal response as a prognostic marker after neoadjuvant therapy for oesophageal cancer.
حسب: Findlay, J, وآخرون
منشور في: (2017)

XPF–ERCC1 Blocker Improves the Therapeutic Efficacy of 5-FU- and Oxaliplatin-Based Chemoradiotherapy in Colorectal Cancer
حسب: Ming-Yii Huang, وآخرون
منشور في: (2023-05-01)

Impact on postoperative complications of changes in skeletal muscle mass during neoadjuvant chemotherapy for gastro‐oesophageal cancer
حسب: den Boer, RB, وآخرون
منشور في: (2020)

Biochemical studies on the role of the XPF-ERCC1 endonuclease in repairing damaged DNA replication forks
حسب: Abdullah, U
منشور في: (2015)

ERCC1/XPF Is Important for Repair of DNA Double-Strand Breaks Containing Secondary Structures
حسب: Shibo Li, وآخرون
منشور في: (2019-06-01)

Neoadjuvant chemotherapy for oesophageal carcinoma - a risk factor for postoperative pneumonia?
حسب: Millo, J, وآخرون
منشور في: (2003)

Cisplatin sensitivity of testis tumour cells is due to deficiency in interstrand-crosslink repair and low ERCC1-XPF expression
حسب: Kaina Bernd, وآخرون
منشور في: (2010-09-01)

Optimised oligonucleotide substrates to assay XPF-ERCC1 nuclease activity for the discovery of DNA repair inhibitors
حسب: Thomas, A, وآخرون
منشور في: (2019)

Oesophageal carcinoma: The prevalence of DNA tumour viruses and therapy
حسب: Sile Li, وآخرون
منشور في: (2022-06-01)

XPF-ERCC1 participates in the Fanconi anemia pathway of cross-link repair.
حسب: Bhagwat, N, وآخرون
منشور في: (2009)

Function and Interactions of ERCC1-XPF in DNA Damage Response
حسب: Maryam Faridounnia, وآخرون
منشور في: (2018-12-01)

Acetylation of XPF by TIP60 facilitates XPF-ERCC1 complex assembly and activation
حسب: Jiajia Wang, وآخرون
منشور في: (2020-02-01)

Human SNM1a and XPF-ERCC1 collaborate to initiate DNA interstrand cross-link repair
حسب: Wang, A, وآخرون
منشور في: (2011)

Human SNM1A and XPF-ERCC1 collaborate to initiate DNA interstrand cross-link repair.
حسب: Wang, A, وآخرون
منشور في: (2011)

Propensity score regression analysis of oesophageal adenocarcinoma treatment with surgery alone or neoadjuvant chemotherapy
حسب: A. G. M. T. Powell, وآخرون
منشور في: (2020-08-01)

Differential clonal evolution in oesophageal cancers in response to neo-adjuvant chemotherapy
حسب: Findlay, J, وآخرون
منشور في: (2016)

Effect of neoadjuvant chemotherapy on the immune microenvironment of gynaecological tumours
حسب: Jing Xue, وآخرون
منشور في: (2023-12-01)

Neoadjuvant Intraperitoneal and Systemic Chemotherapy Versus Neoadjuvant Systemic Chemotherapy With Docetaxel, Oxaliplatin, and S-1 for Gastric Cancer With Peritoneal Metastasis: A Propensity Score Matched Analysis
حسب: Xin Zhang, وآخرون
منشور في: (2021-07-01)

A “Inscrição do Harém” de Xerxes (XPf): introdução crítica, tradução de XPf/OP para o português, comparação com XPf/AB e comentários
حسب: Matheus Treuk Medeiros de Araújo
منشور في: (2024-05-01)

Survival after curative chemoradiotherapy or neoadjuvant therapy and surgery converges in higher-risk patients with oesophageal cancer
حسب: Rana, M, وآخرون
منشور في: (2021)

Additional benefit of ¹⁸F-fluorodeoxyglucose integrated positron emission tomography/computed tomography in the staging of oesophageal cancer.
حسب: Gillies, R, وآخرون
منشور في: (2011)

NEOSCOPE: A randomised phase II study of induction chemotherapy followed by oxaliplatin/capecitabine or carboplatin/paclitaxel based pre-operative chemoradiation for resectable oesophageal adenocarcinoma
حسب: Mukherjee, S, وآخرون
منشور في: (2017)

Additional benefit of 18F-fluorodeoxyglucose integrated positron emission tomography/computed tomography in the staging of oesophageal cancer
حسب: Gillies, R, وآخرون
منشور في: (2010)

The implications of a pathological complete response of the primary tumour after neoadjuvant chemotherapy for breast cancer on axillary surgery
حسب: Mina M. G. Youssef, وآخرون
منشور في: (2021-02-01)